CLINICAL RESEARCH SERVICES AGREEMENT BETWEEN YM BIOSCIENCES, INC. AND PHARM- OLAM INTERNATIONAL LTD.Clinical Research Services Agreement • September 24th, 2004 • Ym Biosciences Inc • Pharmaceutical preparations • Ontario
EX-10.8 5 d365958dex108.htm CLINICAL RESEARCH SERVICES AGREEMENT CLINICAL RESEARCH SERVICES AGREEMENT This Agreement, made as of 25 June 2010 (the “Effective Date”), is by and between: • PSI CRO AG, incorporated in Switzerland, having its registered...Clinical Research Services Agreement • May 5th, 2020 • England
• Alchemia Oncology Pty Ltd. Incorporated in Australia, having its principal place of business at 31 HI-Tech Court, Brisbane Technology Court, Eight Mile Plains, Queensland, Australia (“Sponsor”)
CHANGE ORDER FORMClinical Research Services Agreement • February 13th, 2007 • Advaxis, Inc. • Pharmaceutical preparations
This Change Order 1 “CO1” is hereby incorporated into the terms and conditions of the Clinical Research Services Agreement dated 04 December 2005 (hereinafter referred to as the “Agreement”) by and between Pharm-Olam International (UK) Limited, (hereinafter referred to as “POI”) and Advaxis, Inc, (hereinafter referred to as “Client”).
ContractClinical Research Services Agreement • August 23rd, 2012 • Audeo Oncology, Inc. • Pharmaceutical preparations
[***] DENOTES CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT
CLINICAL RESEARCH SERVICES AGREEMENT BETWEEN YM BIOSCIENCES, INC. AND PHARM- OLAM INTERNATIONAL LTD. YB1002-203TaxotereClinical Research Services Agreement • September 22nd, 2008 • Ym Biosciences Inc • Pharmaceutical preparations • Ontario
This Clinical Research Services Agreement (this Agreement) is made and entered into effective as of 10 December 2004 (the “Effective Date”), by and between YM BIOSCIENCES, INC. (hereafter “YM”), a Canadian corporation, with its principal office at 5045 Orbitor Drive, Building 11, Suite 400, Mississauga, Ontario L4W 4Y4, Canada, and PHARM-OLAM INTERNATIONAL Ltd. (hereafter “POI”), a Texas limited partnership, with its principal office at 450 N Sam Houston Parkway, Suite 250, Houston, TX 77060, United States.
CLINICAL RESEARCH SERVICES AGREEMENTClinical Research Services Agreement • September 23rd, 2004 • CardioVascular BioTherapeutics, Inc. • Maryland
This AGREEMENT, entered into as of October 24, 2001, is by and between Clinical Cardiovascular Research, LLC, a limited liability company established under the laws of the Commonwealth of Virginia, with offices located at Montvale Center, 18310 Montgomery Village Avenue, Suite 620, Gaithersburg, Maryland 20879 (hereinafter referred to as “C2R”), and Cardio Vascular Genetic Engineering, having its principal place of business at 14272 Franklin Avenue, Suite 110, Tustin, CA 92780 (hereinafter referred to as “Sponsor”).
CLINICAL RESEARCH SERVICES AGREEMENT BETWEEN YM BIOSCIENCES, INC. AND PHARM- OLAM INTERNATIONAL LTD. YB1002-203TaxotereClinical Research Services Agreement • March 4th, 2010 • Ym Biosciences Inc • Pharmaceutical preparations • Ontario
This Clinical Research Services Agreement (this Agreement) is made and entered into effective as of 10 December 2004 (the “Effective Date”), by and between YM BIOSCIENCES, INC. (hereafter “YM”), a Canadian corporation, with its principal office at 5045 Orbitor Drive, Building 11, Suite 400, Mississauga, Ontario L4W 4Y4, Canada, and PHARM-OLAM INTERNATIONAL Ltd. (hereafter “POI”), a Texas limited partnership, with its principal office at 450 N Sam Houston Parkway, Suite 250, Houston, TX 77060, United States.
CLINICAL RESEARCH SERVICES AGREEMENT BETWEEN ADVAXIS, INC AND APOTHECARIES LIMITED.Clinical Research Services Agreement • February 13th, 2007 • Advaxis, Inc. • Pharmaceutical preparations • Delhi
This Clinical Research Services Agreement (this Agreement) is made and entered into effective as of 28 Oct. 2006, by and between Advaxis, Inc. (hereafter “THE COMPANY”), a Delaware Company with its principal office at 675 Route 1, North Brunswick, New Jersey 08902, and APOTHECARIES LIMITED. (hereafter “APOTHECARIES ”), a corporation organized under the laws of India, with its principal office at 579, Devli, East Sainik Farms, New Delhi 110062, India.
CLINICAL RESEARCH SERVICES AGREEMENTClinical Research Services Agreement • December 20th, 2007 • ChemoCentryx, Inc. • Pharmaceutical preparations
THIS CLINICAL RESEARCH SERVICES AGREEMENT (“Agreement”) made this 12th day of October 2006 (“Effective Date”), by and between CHEMOCENTRYX, INC., a Delaware corporation with its principal executive offices located at 850 Maude Avenue, Mountain View, CA 94043 (“Sponsor”), and KENDLE INTERNATIONAL INC., with its principal executive offices located at 441 Vine Street, 1200 Carew Tower, Cincinnati, OH 45202 (“Kendle”). Kendle and Sponsor may each be referred to individually as a “Party,” and collectively, as “Parties.”
